You are here
Search our small molecule opportunities against novel cancer targets and pathways. We have drug discovery, pre-clinical and clinical stage opportunities available for co-development and/or licensing.
CRT is seeking a co-development or licensing partner to take this Clinical Development Candidate into Phase I clinical studies.Read more
CRT is seeking a co-development or licensing partner to drive candidate selection and entry into formal pre-clinical studies.Read more
Cancer Research Technology is offering prospective commercial partners global therapeutic rights to the FLT3-FAK-VEGFR3 triple kinase inhibitor programme on an exclusive basis.Read more